Recombinant Mal d 1 is a reliable diagnostic tool for birch pollen allergen-associated apple allergy

被引：16
|
作者：
Kollmann, Dagmar [1 ]
Geroldinger-Simic, Marija [1 ]
Kinaciyan, Tamar [2 ]
Huber, Hans [3 ]
Ebner, Christof [4 ]
Lidholm, Jonas [5 ]
Bohle, Barbara [1 ]
机构：
[1] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Christian Doppler Lab Immunomodulat, Vienna, Austria
[2] Med Univ Vienna, Dept Dermatol, DIAID, Vienna, Austria
[3] Biomay AG, Vienna, Austria
[4] Allergy Clin, Vienna, Austria
[5] Thermo Fisher Sci, Uppsala, Sweden
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2013年 / 132卷 / 04期
基金：
奥地利科学基金会;
关键词：
IN-VIVO; IMMUNOTHERAPY; TESTS;
D O I：
10.1016/j.jaci.2013.05.030
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：1008 / 1010
页数：4
相关论文
共 50 条
  • [41] Effect of Cultivar, Cultivation and Storage Conditions on the Apple Allergen Mal d 1
    Matthes, A.
    Schmitz-Eiberger, M.
    Scheurer, S.
    Lorenz, A. R.
    I INTERNATIONAL SYMPOSIUM ON HORTICULTURE IN EUROPE, 2009, 817 : 79 - 84
  • [42] Soy allergy due to cross reactions to major birch pollen allergen Bet v 1
    Kleine-Tebbe, J.
    Herold, D. A.
    Vieths, S.
    ALLERGOLOGIE, 2008, 31 (08) : 303 - 313
  • [43] Pressure and temperature stability of the main apple allergen Mal d1
    Somkuti, Judit
    Houska, Milan
    Smeller, Laszlo
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2011, 40 (02): : 143 - 151
  • [44] Pressure and temperature stability of the main apple allergen Mal d1
    Judit Somkuti
    Milan Houska
    László Smeller
    European Biophysics Journal, 2011, 40 : 143 - 151
  • [45] Allergy vaccine development using the birch pollen major allergen Bet v 1 as example
    Wallner, M.
    Hauser, M.
    ALLERGOLOGIE, 2012, 35 (02) : 88 - 94
  • [46] Characterisation of recombinant Bet v 1 as a candidate vaccine against birch pollen allergy
    Nony, E.
    Chabre, H.
    Lautrette, A.
    Lemoine, P.
    Couret, M.
    Bobinnec, Y.
    Didierlaurent, A.
    Batard, T.
    Moingeon, P.
    ALLERGY, 2008, 63 : 232 - 232
  • [47] In vitro and in vivo characterization of vaccines for birch pollen allergy based on genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1
    Mahler, V
    Vrtala, S
    Kuss, O
    Diepgen, TL
    Cromwell, O
    Fiebeg, H
    Schuler, G
    Kraft, D
    Valenta, R
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (02) : S255 - S255
  • [48] Impact of storage conditions on the apple allergen Mal d 1 [Einfluss von Lagerungsbedingungen auf das Apfelallergen Mal d 1]
    Kiewning D.
    Baab G.
    Schmitz-Eiberger M.
    Erwerbs-Obstbau, 2012, 54 (4): : 177 - 183
  • [49] Immunological characterization of recombinant Mal d 1, the main allergen from apple (Malus x domestica L. Borkh)
    Savazzini, Federica
    Del Duca, Stefano
    Vegro, Mara
    Cipriani, Francesca
    Ricci, Giampaolo
    Botton, Alessandro
    Pasini, Gabriella
    Dondini, Luca
    Tartarini, Stefano
    SCIENTIA HORTICULTURAE, 2020, 261
  • [50] Characterization of recombinant Mal d 4 and its application for component-resolved diagnosis of apple allergy
    Ma, Y.
    Zuidmeer, L.
    Bohle, B.
    Bolhaarz, S. T. H.
    Gadermaier, G.
    Gonzalez-Mancebo, E.
    Fernandez-Rivas, M.
    Knulst, A. C.
    Himly, M.
    Asero, R.
    Ebner, C.
    van Ree, R.
    Ferreira, F.
    Breiteneder, H.
    Hoffmann-Sommergruber, K.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2006, 36 (08): : 1087 - 1096
12345